However, alpha diversity measures were 12% to 23% lower for HER2+ (n = 12) than HER2− (n = 25) breast cancer; including lower OTU (p = 0.033), Chao1 index (p = 0.073), and Shannon index (p = 0.035). The gene discussed is ERBB2; the disease is breast carcinoma.